The contribution of medical physics to the development of psoralen photochemotherapy (PUVA) in the UK: A personal reminiscence

Physics in Medicine and Biology

Volumn 51, Issue 13, 2006, Pages

  Diffey, Brian ^a,b,c  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b Regional Medical Physics Department   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING DRUG; PSORALEN PHOTOCHEMOTHERAPY (PUVA); SKIN DISORDERS; THERAPY;

DRUG DOSAGE; IRRADIATION; MEDICAL PROBLEMS; PHOTOSENSITIZERS; ULTRAVIOLET RADIATION;

DERMATOLOGY;

BERGAPTEN; CADMIUM SULFIDE; COAL TAR; CORTICOSTEROID; DITHRANOL; DNA; EMOLLIENT AGENT; FREE RADICAL; GALLIUM ARSENIDE; METHOXSALEN; PSORALEN; REACTIVE OXYGEN METABOLITE;

CATARACT; ERYTHEMA; EYE PROTECTION; HUMAN; NAUSEA; NONHUMAN; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY; PHYSICS; PRIORITY JOURNAL; PSORIASIS; PUVA; REVIEW; SKIN DISEASE; SPECTACLES; ULTRAVIOLET B RADIATION; UNITED KINGDOM;

FICUSIN; GREAT BRITAIN; HEALTH PHYSICS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHOTOSENSITIZING AGENTS; PUVA THERAPY; SKIN DISEASES;

EID: 33745508919     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/13/R14     Document Type: Review

References (69)

1. Brücke J, Tanew A, Ortel B and Hönigsmann H 1991 Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis Br. J. Dermatol. 124 372-4
2. Caird A and Rogers S 1999 Disposable face masks for PUVA: what the patients think Br. J. Dermatol. 140 782
3. Challoner A V J and Diffey B L 1977 Problems associated with ultraviolet dosimetry in the photochemotherapy of psoriasis Br. J. Dermatol. 97 643-8
4. Cloud T M, Hakin R and Griffin A C 1961 Photosensitisation of the eye with methoxsalen: II. Chronic effects Arch. Dermatol. 66 689-94
5. Coleman A J, Collins M and Saunders J E 2000 Traceable calibration of ultraviolet meters used with broadband, extended sources Phys. Med. Biol. 45 185-96
6. Cox N H, Farr P M and Diffey B L 1989 A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema Arch. Dermatol. 125 1653-7
7. Currie G D, Evans A L, Smith D, Martin C J, McCalman S and Bilsland D 2001 An automated dosimetry system for testing whole-body ultraviolet phototherapy cabinets Phys. Med. Biol. 46 333-46
8. Davey J B, Diffey B L and Miller J A 1981 Eye protection in psoralen photochemotherapy Br. J. Dermatol. 104 295-300
9. Dawe R, Russell S and Ferguson J 1996 Borrowing from museums and industry: two photoprotective devices Br. J. Dermatol. 135 1016-7
10. Diffey B L 1978 PUVA: a review of ultraviolet dosimetry Br. J. Dermatol. 98 703-6
11. Diffey B L 1981 A mathematical model of the biologically effective dose of solar UVA received by patients undergoing oral psoralen photochemotherapy for psoriasis Phys. Med. Biol. 26 1129-35
12. Diffey B L 1992 Calibration of ultraviolet A dosemeters used in psoralen photo-chemotherapy (PUVA) Scope 1 47-50
13. Diffey B L and Challoner A V J 1978 Absolute radiation dosimetry in photochemotherapy Phys. Med. Biol. 23 1124-9
14. Diffey B L, Challoner A V and Key P J 1980 A survey of the ultraviolet radiation emissions of photochemotherapy units Br. J. Dermatol. 102 301-6
15. Diffey B L, De Berker D A, Saunders P J and Farr P M 1993 A device for phototesting patients before PUVA therapy Br. J. Dermatol. 129 700-3
16. Diffey B L, Elkerton T R and Diprose M F 1976 A simple light meter for use in dermatology Med. Biol. Eng. 14 101-2
17. Diffey B L, Harrington T R and Challoner A V J 1978 A comparison of the anatomical uniformity of irradiation in two different photochemotherapy units Br. J. Dermatol. 99 361-3
18. Diffey B L, Harrington T R and Davis A 1977 The anatomical distribution of ultraviolet radiation in photochemotherapy Phys. Med. Biol. 22 1014-6
19. Diffey B L and Hart G 1997 Ultraviolet and Blue Light Phototherapy: Principles, Sources, Dosimetry and Safety (New York: The Institute of Physics and Engineering in Medicine)
20. Diffey B L and Miller A 1978 A detector for monitoring the output of ultraviolet radiation sources used in the photochemotherapy of psoriasis Phys. Med. Biol. 23 514-7
21. Diffey B L and Miller J A 1980 A comment on the routine testing of sunglasses in photochemotherapy Br. J. Dermatol. 102 665-8
22. Diffey B L and Roelandts R 1986 Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy J. Am. Acad. Dermatol. 15 1209-13
23. Farr P M and Diffey B 1991 PUVA treatment of psoriasis in the United Kingdom Br. J. Dermatol. 124 365-7
24. Farr P M, Diffey B L, Higgins E M and Matthews J N 1991 The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy Br. J. Dermatol. 124 443-8
25. Freeman R G and Troll D 1969 Photosensitisation of the eye by 8-methoxypsoralen Arch. Ophthalmol. 53 449-53
26. Fulljames C A and Welsh A D 2000 Measurement of patient dose in ultraviolet therapy using a phantom Br. J. Dermatol. 142 748-51
27. Gordon P M, Diffey B L, Matthews J N S and Farr P M 1999 A randomized comparison of narrow-band TL-01 phototherapy and psoralen-UVA photochemotherapy for psoriasis J. Am. Acad. Dermatol. 41 728-32
28. Halpern S M et al 2000 Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group Br. J. Dermatol. 142 22-31
29. Ibbotson S H and Farr P M 1999 The time-course of psoralen ultraviolet A (PUVA) erythema J. Invest. Dermatol. 113 346-9
30. Lakshmipathi T, Gould P W, Mackenzie L A, Johnson B E and Frain-Bell W 1977 Photochemotherapy in the treatment of psoriasis Br. J. Dermatol. 96 587-94
31. Langmack K A 1998 An insight into the contribution of self-shielding and lamp reflectors to patient exposure in phototherapy units Phys. Med. Biol. 43 207-14
32. Lever L R and Farr P M 1994 Skin cancers or premalignant lesions occur in half of high-dose PUVA patients Br. J. Dermatol. 131 215-9
33. Lloyd J 2004 Variation in calibration of hand-held UV meters for PUVA and narrow band UVB phototherapy Br. J. Dermatol. 150 1162-6
34. Mackenzie L A 1985 UV radiometry in dermatology Photodermatol 2 86-94
35. Martin C J, Clouting H and Aitken A 2003 A study of the correction factor of ultraviolet phototherapy dose measurements made by the indirect method Br. J. Dermatol. 149 1227-31
36. Martin C J, Currie G D and Pye S D 1999 The importance of radiometer angular response for ultraviolet phototherapy dosimetry Phys. Med. Biol. 44 843-55
37. Martin C J and Pye S D 2000 A study of the directional response of ultraviolet radiometers: II. Implications for ultraviolet phototherapy derived from computer simulations Phys. Med. Biol. 45 2713-29
38. McLelland J, Fisher C, Farr P M, Diffey B L and Cox N H 1991 The relationship between plasma psoralen concentration and psoralen-UVA erythema Br. J. Dermatol. 124 585-90
39. Moseley H 2001 Scottish UV dosimetry guidelines Photodermatol. Photoimmunol. Photomed. 17 230-3
40. Moseley H, Cox N H and MacKie R M 1988 The suitability of sunglasses used by patients following ingestion of psoralen Br. J. Dermatol. 118 247-53
41. Moseley H, Diffey B L, Marks J M and Mackie R M 1981 Personal solar UV-A doses received by patients undergoing oral psoralen photochemotherapy for psoriasis Br. J. Dermatol. 105 573-7
42. Moseley H and Jones S K 1990 Clear ultraviolet blocking lenses for use by PUVA patients Br. J. Dermatol. 123 775-81
43. Moseley H and Perkins W 1992 Clear eyewear for PUVA patients Br. J. Dermatol. 127 657-8
44. Mountford P J 1986 Phototherapy and photochemotherapy ultraviolet irradiation equipment Photodermatol. 3 83-91
45. Mountford P J 1990 A comparative assessment of the ultraviolet radiation transmission of sunglasses for patients receiving photochemotherapy Clin. Phys. Physiol. Meas. 11 333-41
46. Mountford P J, Pepper M G and Goldin D 1983 A UVA meter for monitoring the irradiance within a photochemotherapy unit Phys. Med. Biol. 28 177-84
47. Norris P G et al 1994 British Photodermatology Group guidelines for PUVA Br. J. Dermatol. 130 246-55
48. Parrish J A, Fitzpatrick T B, Tanenbaum L and Pathak M 1974 Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light New Eng. J. Med. 291 1207-11
49. Pathak M and Fitzpatrick T B 1992 The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD J. Photochem. Photobiol. B 14 3-22
50. Pye S D and Martin C J 2000 A study of the directional response of ultraviolet radiometers: I. Practical evaluation and implications for ultraviolet measurement standards Phys. Med. Biol. 45 2701-12
51. Roelandts R 1991 The history of photochemotherapy Photodermatol. Photoimmunol. Photomed. 8 184-9
52. Roelandts R, Diffey B L and Bocquet J L 1988 Une dosimétrie UVA précise en photobiologie et en photodermatologie est-elle une illusion? Ann. Dermatol. Venereol. 115 1261-4
53. Rogers S, Marks J, Shuster S, Vella Briffa D, Warin A and Greaves M 1979 Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis Lancet i 455-8
54. Sakuntabhai A, Diffey B L and Farr P M 1993a Response of psoriasis to psoralen-UVB photochemotherapy Br. J. Dermatol. 128 296-300
55. Sakuntabhai A, Diffey B L and Farr P M 1995 Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment Br. J. Dermatol. 133 919-23
56. Sakuntabhai A, Farr P M and Diffey B L 1993b PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity Br. J. Dermatol. 128 561-5
57. Sakuntabhai A, Sharpe G R and Farr P M 1993c Response of psoriasis to twice weekly PUVA Br. J. Dermatol. 128 166-71
58. Scott B O 1967 Clinical uses of ultraviolet radiation Therapeutic Electricity and Ultraviolet Radiation ed S Licht (CT: Elizabeth Licht) p 325-78
59. Serup J 2003 Niels R Finsen: first Nobel laureate in medicine. Forum for Nord Derm Ven 8 98-100
60. Steele M C and Diffey B L 1997 A disposable face mask for PUVA and ultraviolet phototherapy Br. J. Dermatol. 137 151-2
61. Stern R S and Laird N 1994 The carcinogenic risk of treatments for severe psoriasis: photochemotherapy follow-up study Cancer 73 2759-64
62. Stern R S, Nichols K T and Vakeva L H 1997 Malignant melanoma in patients treated for psoriasis with methoxalen (psoralen) and ultraviolet A radiation (PUVA) New. Eng. J. Med. 336 1041-5
63. Stevenson I H, Kenicer K J A, Johnson B E and Frain-Bell W 1981 Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis Br. J. Dermatol. 104 47-51
64. Stobbart D and Diffey B L 1980 A comparison of some commercially available UV-A meters used in photochemotherapy Clin. Phys. Physiol. Meas. 1 267-73
65. Studniberg H M and Weller P 1993 PUVA, UVB, psoriasis, and nonmelanoma skin cancer J. Am. Acad. Dermatol. 29 1013-22
66. Taylor D K et al 2002 Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group Workshop Br. J. Dermatol. 146 755-63
67. Turner R J, Farr P M and Walshaw D 1998 Many patients with psoriasis use sunbeds Br. Med. J. 317 412
68. Turner R J, Walshaw D, Diffey B L and Farr P M 2000 A controlled study of ultraviolet A sunbed treatment of psoriasis. Br. J. Dermatol. 143 957-63
69. Wolff K, Gschnait F, Hönigsmann H, Konrad K, Parrish J A and Fitzpatrick T B 1977 Phototesting and dosimetry for photochemotherapy Br. J. Dermatol. 96 1-10